ADAM17 and type 2 diabetes mellitus: We hypothesized that hyperglycemia could activate PKC-α-MAPK14-ADAM17 signaling in the SG, enhancing postganglionic neuronal excitability and CSNA in T2DM, which provides a novel glial mechanism of diabetic sympathetic overexcitation.